Gary Richardson - Concepedia

Author

Gary Richardson

Also Known As

G E Richardson, G Richardson, G. E. Richardson, G. Richardson, G.E. Richardson, GARY E. RICHARDSON, Gary E Richardson, Gary E. Richardson, Gary Edward Richardson, Gary Richardson

190

Publications

7.3K

Citations

H-Index

Concepts

All Affiliations

Cabrini Hospital Peter MacCallum Cancer Centre The University of Melbourne Monash University Monash Medical Centre

About

Gary Richardson is an author at Cabrini Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	31	1.7K
2	Health Sciences	6	6	166
3	Cell Biology	4	4	67
4	Cellular Therapies	2	2	23
5	Social Sciences	1	1	79

Gary Richardson

Publications

Citations

H-Index

Page 1

	Year	Citations
Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Eric Van Cutsem, Marc Peeters, Salvatore Siena, Journal of Clinical Oncology	2007	2K
Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer Stephen Chan, Kay Friedrichs, D. Noel, Journal of Clinical Oncology	1999	638
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study Éric Pujade-Lauraine, Keiichi Fujiwara, Jonathan A. Ledermann, The Lancet Oncology Chemotherapy Versus ChemotherapyOncologyPlatinum-refractory Ovarian CancerMedicineMetronomic Therapy	2021	374
Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial Bradley J. Monk, Andrés Poveda, Ignace Vergote, The Lancet Oncology OncologyPlacebo-controlled Phase 3Metronomic TherapyClinical TrialsGynecology	2014	304
Tirapazamine Plus Cisplatin Versus Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Report of the International CATAPULT I Study Group Joachim von Pawel, Reinhard von Roemeling, U. Gatzemeier, Journal of Clinical Oncology	2000	285
Smoking Cessation after Successful Treatment of Small-Cell Lung Cancer Is Associated with Fewer Smoking-related Second Primary Cancers Gary Richardson Annals of Internal Medicine	1993	236
Phase II Comparator Study of Oral Versus Intravenous Topotecan in Patients With Chemosensitive Small-Cell Lung Cancer Joachim von Pawel, U. Gatzemeier, Jean-Louis Pujol, Journal of Clinical Oncology	2001	233
Randomized, Double-Blind, Placebo-Controlled Phase II Study of AMG 386 Combined With Weekly Paclitaxel in Patients With Recurrent Ovarian Cancer Beth Y. Karlan, Amit M. Oza, Gary Richardson, Journal of Clinical Oncology	2011	225
Initial clinical results of linac-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas Michihide Mitsumori, Dennis C. Shrieve, Eben Alexander, International Journal of Radiation OncologyBiologyPhysics Pituitary AdenomasRadiation TherapyTreatment VerificationInitial Clinical ResultsSurgery	1998	211
Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics Allan Lipton, Karim Fizazi, Alison Stopeck, European Journal of Cancer	2015	113

Page 1